• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia:

tetano

Editor, Senior Moderator
Vaccine
Article in Press, Uncorrected Proof - Note to users
doi:10.1016/j.vaccine.2011.07.087 | How to Cite or Link Using DOI
Permissions & Reprints


Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study
Purchase
$ 31.50

Allen C. Chenga, b, Corresponding Author Contact Information, E-mail The Corresponding Author, Tom Kotsimbosa, b, Heath A. Kellyc, Louis B. Irvingd, e, Simon D. Bowlerf, Simon G.A. Browng, h, i, Mark Holmesj, k, Christine R. Jenkinsl, m, n, Philip Thompsoni, Graham Simpsono, Richard Wood-Bakerp, q, Sanjaya N. Senanayaker, s, Stephen J. Bradyt, David L. Patersonu, v, Peter A. Warkw, x, John W. Uphamu, y, Tony M. Kormana, z, Dominic E. Dwyerl, A, Grant W. Watererg, h and Paul M. Kellys, B

A Westmead Hospital, Australia

B ACT Government Health Directorate, Australia

a Monash University, Australia

b Alfred Hospital, Australia

c Victorian Infectious Diseases Reference Laboratory, Australia

d Royal Melbourne Hospital, Australia

e University of Melbourne, Australia

f Mater Adult Hospital, Australia

g Royal Perth Hospital, Australia

h Western Australian Institute for Medical Research, Australia

i University of Western Australia, Australia

j The University of Adelaide, Australia

k Royal Adelaide Hospital, Australia

l University of Sydney, Australia

m Concord Hospital, Australia

n Woolcock Institute of Medical Research, Australia

o Cairns Base Hospital, Australia

p Royal Hobart Hospital, Australia

q Menzies Research Institute, Australia

r Canberra Hospital, Australia

s Australian National University, Australia

t Alice Springs Hospital, Australia

u University of Queensland, Australia

v Royal Brisbane and Women's Hospital, Australia

w University of Newcastle, Australia

x John Hunter Hospital, Australia

y Princess Alexandra Hospital, Australia

z Southern Health, Australia
Received 28 March 2011;
revised 4 July 2011;
accepted 19 July 2011.
Available online 31 July 2011.

Abstract

We aimed to estimate the effectiveness of H1N1/09 containing influenza vaccines against hospitalization from influenza in Australia. We performed a test-negative case control study in patients hospitalized in 15 sentinel Australian hospitals between March and November 2010, comparing influenza vaccination (H1N1/09 monovalent or 2010 seasonal trivalent) in hospitalized patients with PCR-confirmed influenza compared to PCR-negative controls. Between March and November 2010, 1169 hospitalized patients were tested for suspected influenza, of which influenza vaccine status was ascertained in 165/238 patients with H1N1/09 influenza, 40/64 with seasonal influenza and 558/867 test negative controls; 24% of H1N1/09 cases, 43% of seasonal influenza cases and 54% of controls were vaccinated. VE against hospitalisation with H1N1/09 influenza after adjusting for age, medical comorbidities and pregnancy status was estimated at 49% (95% CI: 13%, 70%). Influenza vaccination was associated with a reduction in hospitalisation caused by H1N1/09 influenza in the 2010 southern hemisphere winter season.

http://www.sciencedirect.com/science/article/pii/S0264410X11011376
 
Back
Top Bottom